✦ LIBER ✦
Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advancedBRAFV600- mutated melanoma (BRIM7)
✍ Scribed by Puzanov, Igor; McArthur, Grant; Gonzalez, Rene; Pavlick, Anna; Hamid, Omid; Gajewski, Thomas F; Yin, Ming; Fredrickson, Jill; Choong, Nicholas; Ribas, Antoni
- Book ID
- 125401234
- Publisher
- BioMed Central
- Year
- 2014
- Tongue
- English
- Weight
- 92 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1479-5876
No coin nor oath required. For personal study only.